Showing results (1-10 of 160) with videos related to
Sort By:
Pageof 16
Clinical Pharmacology and Therapeutics|November 10, 2018
Modern Human Immunodeficiency Virus Therapy: Progress and ProspectsCharles FlexnerCurrent Opinion in HIV and AIDS|June 28, 2022
The future of long-acting agents for preexposure prophylaxisCharles FlexnerNature Reviews. Drug Discovery|October 13, 2007
HIV drug development: the next 25 yearsCharles FlexnerCurrent Opinion in HIV and AIDS|May 26, 2018
Antiretroviral implants for treatment and prevention of HIV infectionCharles FlexnerAmerican Journal of Physiology. Cell Physiology|April 13, 2004
Diarrhea-associated HIV-1 APIs potentiate muscarinic activation of Cl- secretion by T84 cells via prolongation of cytosolic Ca2+ signalingPaul A Rufo, Patricia W Lin, Adriana Andrade, et al.Current Opinion in HIV and AIDS|October 9, 2013
The antiretroviral drug pipeline: prospects and implications for future treatment researchCharles Flexner, Michael SaagThe Journal of Antimicrobial Chemotherapy|December 7, 2010
Emerging antiretroviral drug interactionsPaul A Pham, Charles FlexnerAIDS (London, England)|May 5, 2017
The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy developmentJanessa M Smith, Charles FlexnerAIDS Research and Therapy|November 27, 2018
Ageing in patients with chronic HIV infection: impact of hypercoagulationStephen J Kent, Charles FlexnerAnnual Review of Medicine|October 26, 2018
Long-Acting HIV Drugs for Treatment and PreventionRoy M Gulick, Charles FlexnerPageof 16